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Edited by Gianni CesareniAbstract The nuclear receptor constitutive active/androstane
receptor CAR is a drug-sensing transcription factor. Upon acti-
vation by various drugs such as phenobarbital (PB), CAR trans-
locates from the cytoplasm into the nucleus to regulate the genes
that encode enzymes and proteins involved in hepatic metabolism.
Here, we have shown the presence of CAR at the cell membrane
of mouse livers, using Car+/+ and Car/ mice. Levels of the cell
membrane CAR increased after PB treatment. The CAR exists
as a large approximately 160 kDa complex. Thus, CAR under-
goes PB-induced translocation to the cell membrane, indicating
that CAR may exert a non-genomic action.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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transport1. Introduction
CAR was originally characterized as the nuclear receptor
that is activated by phenobarbital (PB) to upregulate the tran-
scription of cytochrome P450 2B genes [1–3]. The role of CAR
in PB-activated transcription was soon conﬁrmed in experi-
ments using Car/ mice [4]. Subsequently, CAR was impli-
cated as a coordinate transcription factor in the regulation of
a variety of hepatic metabolic pathways [5,6]. CAR is retained
in the cytoplasm of non-treated mouse hepatocytes and trans-
locates to the nucleus following treatment with PB and PB-like
inducers [7,8]. Unlike the nuclear hormone receptors in which
direct binding of ligands dictates their nuclear translocation,
CAR translocation can be triggered without direct binding
of PB. PB may trigger a signal that regulates the translocation,
as suggested by the fact that PB-induced CAR translocation is
repressed by okadaic acid and that cytoplasmic CAR:Hsp90
complex recruits protein phosphatase 2A in response to PBAbbreviations: PB, phenobarbital; BN-PAGE, blue native polyacryl-
amide gel electrophoresis; SDS–PAGE, sodium dodecyl sulfate poly-
acrylamide gel electrophoresis
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to speculate that it takes place at the cell membrane. While no
evidence for the membrane receptor of PB has been presented
yet, the speculation prompted us to investigate the localiza-
tion of CAR at the cell membrane and the eﬀect of PB on this
localization.
The cell membrane estrogen receptor a (ERa) has been char-
acterized in variety of cells [10,11]. Upon estrogen binding, the
membrane ERa (mER) exerts non-genomic action by initiating
downstream signaling cascades that eventually act on target
transcription factors to regulate gene expression [10–12]. Here,
we performed cell fractionation and Western blot analysis to
show the presence of CAR at the cell membrane of mouse liv-
ers and its rapid increase after PB treatment, using the corre-
sponding membrane fraction of Car/ mice as a negative
control. Moreover, two-dimensional gel electrophoresis [blue-
native and sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS–PAGE)] reveal that CAR forms a large mem-
brane complex.2. Materials and methods
2.1. Animals and drug treatments
Car/ and Car+/+ mice were obtained as described previously [13].
PB (Sigma, St. Louis, MO) in saline or the saline vehicle was injected
through tail vein at a dose of 100 mg/kg of body weight.
2.2. Sub-cellular fractionation
To prepare the cell membrane fraction, livers from three non-treated
or PB-treated mice were homogenized in 10 mM HEPES buﬀer, (pH
7.5) containing 250 mM sucrose, 0.1 mM EDTA, 0.1 mM EGTA
and 1.0 mM phenylmethylsulfony ﬂuoride, and then centrifuged at
10000 · g for 30 min. The resulting pellet was re-homogenized with
the same buﬀer and centrifuged at 800 · g for 5 min to remove nuclei.
From resulting supernatant, cell membranes were prepared by percoll
density centrifugation at 35000 · g for 30 min and washed with buﬀer
according to methods previously described [14,15]. Liver nuclear ex-
tract was prepared as described previously [1]. To prepare mitochon-
drial, microsomal and Golgi fractions, livers from three PB-treated
Car+/+ mice were homogenized in 10 mM Tris–HCl (pH 7.4) contain-
ing 0.25 M sucrose. The homogenate was centrifuged at 1000 · g for
10 min. The supernatant was then centrifuged at 3000 · g for 10 min
to obtain heavy mitochondria pellet. The resulting supernatant was
again centrifuged at 17000 · g for 20 min. The resulting pellet was
re-suspended in the homogenization buﬀer, from which microsomal
fraction was prepared by centrifugation at 100000 · g for 30 min, or
light Golgi fraction was prepared by a 0.25–1.55 M sucrose density
gradient centrifugation at 100000 · g for 60 min. Those fractions were
washed with and homogenized in 10 mM Tris–HCl buﬀer, pH 7.4 that
contained 0.25 M sucrose. Protein concentrations were determined by
Protein Assay (Bio-Rad laboratories, Hercules, CA).European Biochemical Societies.
Fig. 1. The presence of CAR at the cell membrane. (A) Cell membrane
fraction or nuclear extract were prepared from Car+/+ or Car/mouse
liver with or without PB treatment. 40 lg of cell membrane fraction or
nuclear extract from mouse liver was subjected to SDS–PAGE and
detected by Western blot analysis using anti-CAR, anti-caveolin, anti-
lamin B, anti-a tublin and anti-actin antibodies. (B) Cell membrane
fractions were prepared from the livers of Car+/+ (lane 1) or Car/
(lane 2) mice 30 min after PB administration. Microsomal (lane 3),
heavy mitochondria (lane 4) and Golgi (lane 5) fractions were prepared
from the Car+/+ mice treated with PB for 30 min. 40 lg of each fraction
was subjected to SDS–PAGE and probed by Western blot analysis
with anti-CAR, anti-calnexine, anti-prohibitin antibody or anti-58kD
Golgi protein.
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Expression plasmids pYFP-mCAR [8] and pCFP-Mem (BD Biosci-
ences Clontech, Palo Alto, CA) were injected into Car/ mouse via
tail veins using the TransIT in vivo gene delivery system (Mirus, Mad-
ison, WI). Two and ﬁve hr after the injection of plasmids, mice were
injected intraperitoneally with either PB (100 mg/kg body weight) or
Me2 So vehicle and were sacriﬁced three hr after drug treatment. Prep-
aration of liver sections and the detection of tagged proteins by confo-
cal laser scanning microscopy (Zeiss LSM510 META) were performed
as descried previously [16,17]. Liver section on slide was excited at
514 nm (YFP) or 458 nm (CFP).
2.4. Two-dimensional electrophoresis
The cell membrane fraction was incubated with 1% digitonin at 4 C
for 60 min and centrifuged at 10000 · g for 30 min to prepare superna-
tant for electrophoresis. Blue native gel electrophoresis was carried out
as previously described [18–20]. The solubilized cell membrane fraction
was mixed with one tenth volume of 50 mM Bis-Tris/HCl buﬀer (pH
7.0) containing 100 mM aminocaproic acid, 75% sucrose, 5% Cooma-
sie blue G250. For ﬁrst dimension electrophoresis, the solubilized cell
membrane was applied to a 5–16% gradient polyacrylamide gel using
Mighty Small gel caster (Hoefer scientiﬁc instruments, Sanfrancisco,
CA). Electrophoresis was performed using cathode buﬀer with Coo-
massie blue (50 mM Tricine, 15 mM Bis-Tris/HCl, 0.01% Coomassie
blue G250) and anode buﬀer (50 mM Bis-Tris/HCl, pH 7.0) at 4 C.
After top half of the gel was covered with Coomassie blue, the cathode
buﬀer was changed to buﬀer not containing Coomassie blue. Ferritin
(880 and 440 kDa), catalase (232 kDa), and aldolase (158 kDa) were
used as molecular size markers. For second-dimension electrophoresis,
lanes from the ﬁrst-dimension blue native polyacrylamide gel electro-
phoresis (BN-PAGE) were cut out as stripes. Gel strips were equili-
brated in 1· loading buﬀer (Invitrogen, Carlsbad, CA) including 1%
2-mercaptoethanol and placed onto a 10% SDS–PAGE, using a
Mighty Small gel caster. Electrophoresis was performed with Tris–gly-
cine buﬀer (25 mM Tris, 0.2 M glycine, 0.1% SDS).
2.5. Western blot
Proteins were transferred to PVDFmembrane using Hoefer SemiPh-
ior (Amersham Pharmacia Biotech., Piscataway, NJ) with NuPAGE
transfer buﬀer (Invitrogen) after electrophoresis. Immuno-staining
was performed according to standard protocols. SeeBlue Plus2 Pre-
Stained Standard (Invitrogen) was used as molecular weight marker.
The following antibodies were used for Western blotting; anti-caveolin
(a cell membrane marker) (BD Bioscience, San Jose, CA), anti-lamin
B1 (a nuclear membrane marker), anti-actin, anti-a tublin, anti-rabbit
IgG (Santa Cruz biotechnology, Santa Cruz, CA), anti-calnexin (an
endoplasmic reticulum marker), anti-58K Golgi protein (a Golgi mar-
ker), anti-prohibitin (a mitochondrion marker) (Abcam, Cambridge,
MA) and rabbit anti-CAR polyclonal antibody [21].3. Results and discussion
To examine whether CAR is localized at the cell membrane,
cell membrane fractions were prepared from the livers ofCar+/+
and Car/ mice before and after PB treatment. Nuclear frac-
tions were also prepared from the same mice and used as con-
trols to demonstrate the speciﬁcity of anti-CAR antibody and
the lack of CAR in Car/ mice. Western blotting analysis
showed that CAR was present in the cell membrane fraction
from Car+/+ mice before PB treatment, increasing its amount
after PB treatment (Fig. 1A). No such immunoreactive CAR
was detected from the Car/mice. While caveolin (a cell mem-
brane marker) was found in cell membrane fractions, the
nuclear membrane marker lamin B was not detected. The
CAR protein in cell membrane fractions did not appear to be
a contaminant of CAR from the nucleus. Moreover, the cell
membrane fraction contained neither calnexin (an endoplasmic
reticulum marker), prohibitin (a mitochondrion marker), nor
58 kDa Golgi protein (a Golgi marker) (Fig. 1B). Actin butnot tublin was present in all cell membrane fractions
(Fig. 1A), which is reasonable since actin is known to associate
with the cell membrane. Thus, these results clearly show that
CAR protein is localized at the cell membrane, although the
possibility that this localization is mediated by actin can not
be totally eliminated.
To provide additional evidence that supported the ﬁnding of
cell membrane localization of CAR, YFP-mCAR was directly
co-expressed with CFP-Mem (a cell membrane marker pro-
tein) in the liver of Car/ mice. Pictures of the cells represent-
ing characteristic localizations of YFP-mCAR are shown in
Fig. 2. Consistent with the results obtained from Western blot
analysis of subcellular fractions, YFP-mCAR was found to
localize in the cytoplasm and at the cell membrane before PB
treatment but was not observed in the nucleus. In the present
experiment with PB treatment, there were liver cells that ex-
pressed YFP-mCAR both in the nucleus and at the cell mem-
brane (Fig. 2). Various experimental limitations intrinsic to the
over-expression system used, it is diﬃcult to exactly chase a
time-dependent transport of protein, thus making it problem-
atic to correlate the exogenously expressed CAR in a single cell
with what observed by Western blot analysis of the endoge-
nous CAR protein in subcellular fractions. Nevertheless, the
intracellular localization of YFP-mCAR added the supporting
evidence for the cell membrane localization of CAR in the liver
in vivo.
CAR accumulated at the cell membrane in a time-dependent
manner after PB treatment, suggesting that the CAR protein
Fig. 2. Cell membrane localization of mCAR in liver in vivo: YFP-mCAR and CFP-Mem proteins were expressed in the liver of Car/ mice by
injection their expression plasmids via tail vein. The mice were treated with either saline (PB) or PB (+PB) as described in Section 2. Liver sections
were prepared and examined by confocal microscopy for YFP expression (in yellow), CFP expression (in light blue) and Hoechst S33258 (0.5 lg/ml)
staining for nuclei (in dark blue).
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was initially hypothesized that CAR membrane localization
occurs prior to nuclear accumulation upon PB treatment.
However, CAR localization at the cell membrane did not oc-
cur sooner than its localization in the nucleus. The similar
time-dependent accumulation at the cell membrane and in
the nucleus does not support the notion that CAR transloca-
tion to the cell membrane is a prerequisite for nuclear translo-
cation at the present time.Fig. 3. Time-dependent accumulation of CAR at the cell membrane in
response to PB. Cell membrane fractions or nuclear extracts were
prepared from mouse livers at 0, 15, 30 and 60 min intervals after PB
treatment. 40 lg of each cell membrane fraction or nuclear extract was
subjected to SDS–PAGE and probed by Western blot analysis with
anti-CAR, anti-caveolin or anti-lamin B antibody.
Fig. 4. Detection of a large membrane complex of CAR. The cell membran
treated with PB for 30 min. For BN-PAGE/SDS–PAGE two-dimensional elec
PAGE. For the one-dimensional SDS–PAGE (right panel), 40 lg of protein
CAR on the two or one-dimensional gel. Molecular weight markers for BNSince CAR molecule does not have a known membrane an-
chor region, the cell membrane localization of CAR may be
mediated by the association with an intrinsic membrane pro-
tein. We speculated that CAR would exist as a complex with
proteins at the cell membrane. To detect the CAR-containing
protein complex at the cell membrane, we employed BN-
PAGE. BN-PAGE is a method for the isolation of intact
protein complexes. Binding of Coomassie blue G250 shifts iso-
electric point of a given protein to more a negative value with-
out dissociating the constituting complex, making it to migrate
toward further anode. Coomassie blue G250-bound membrane
protein becomes more negatively charged; a large membrane
complex becomes accessible to move into a native polyacrya-
mide gel. Solubilized cell membrane fractions from Car+/+
mice and Car/ mice with PB treatment were separated by
two-dimensional electrophoresis using BN-PAGE and SDS–
PAGE. A CAR protein complex was detected around
160 kDa by Western blotting (Fig. 4). This size of the expected
complex is consistent with the result of gel ﬁltration fraction-
ation (data not shown).
The membrane-initiated rapid steroid signaling of thyroid
hormone, vitamin D and estrogen receptors has been reported
[22–24]. In the case of thyroid hormone, it eﬀects on ion chan-
nel and ion jump activities at the cell membrane and also stim-
ulates MAPK (mitogen-activated protein kinase) cascade [22].
Vitamin D receptors interact with scaﬀold proteins, move toe fractions were prepared from the livers of Car+/+ and Car/ mice
trophoresis, 120 lg of each cell membrane fraction was loaded on BN-
was loaded. CAR was detected by Western blotting. Arrows indicate
-PAGE are indicated above gel.
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including Src [22,23]. Furthermore, E2 treatment increases the
interaction of ER-a with one of G-protein coupled receptor
Gai at the cell membrane in the COS7 and endothelial cells,
activating MAPK and Akt signalings [22–24]. CAR may also
associate with some of G-protein coupled proteins or other sig-
naling proteins at the cell membrane and have similar rapid
signaling pathway in response to xenobiotics such as PB.
The signiﬁcance of membrane-associated CAR and its increase
upon PB treatment is unclear at the moment and needs to be
explored in future investigations. Nevertheless, our present
ﬁndings that CAR forms a large complex at the cell membrane
in mouse liver in response to PB treatment is an important ﬁrst
step to elucidate potential non-genomic action of CAR in liver.
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